2010 Annual Meeting

Coming Events

Genta Incorporated Reports Fourth Quarter and 2009 Year-End Financial Results
March 29th, 2010
Berkeley Heights, NJ

SEC Filings

Section 16 Filings (3, 4, 5,) for Directors and Executive Officers.

PIPELINE

	Overview

	Tesetaxel - Mechanism of Action - Preclinical Data - Publications - Clinical Development

	Genasense^® - Antisense Technology - Mechanism of Action - Preclinical - Clinical Development - Information for Patients

	Oral Gallium - Mechanism of Action - Preclinical - Publications - Clinical Development